Thymus Hormone Linked to Lower Age-Related Inflammation

• Inflammatory myeloid cells become more common with age in both mice and people — Myeloid cells are frontline immune cells, including monocytes, macrophages, granulocytes, and dendritic cells. In aged mice, roughly comparable to people in their 50s to 70s, researchers found a marked increase in myeloid cells producing the inflammatory cytokines IL-1α, IL-1β, IL-6, and TNF-α.

People followed the same pattern. In blood samples from 90 healthy human donors, the share of cytokine-producing myeloid cells rose along with age. It was also higher in donors aged 60 to 87 than in donors aged 21 to 33.

• The same inflammatory signature showed up in human breast tumors — Working from the published dataset of 26 breast tumors from patients aged 35 to 88, the team compared the eight youngest with the eight oldest, all untreated before surgery. Tumors from the older patients contained a higher proportion of myeloid cells. Those cells were also running different genetic programs.

In younger patients, they favored genes for flagging threats to the rest of the immune system, while in older patients, they favored genes for inflammatory messengers, damage signals that injured cells release, inflammasome components, and regulators of NF-κB, the master switch that turns inflammatory genes on.

• Sharing a bloodstream with a young mouse lowered the inflammatory signal — To test where the difference originated, the researchers used heterochronic parabiosis, a technique in which an older and a younger mouse are surgically joined so they share one bloodstream.

In these pairs, inflammatory myeloid cells in the aged animal dropped to levels comparable to young-young pairs, and aged animals bearing tumors showed delayed tumor progression and improved survival compared with aged-aged pairs.

• Bone marrow transplant experiments narrowed it further — Aged bone marrow placed into a young host produced far fewer inflammatory signaling proteins than the same marrow in an aged host. Young marrow placed into an aged host also became more inflammatory.

The host environment, rather than the age of the immune cells, appeared to govern the outcome. The effect persisted in mice engineered to lack T and B cells, indicating it did not depend on adaptive immunity.

• A database search pointed toward the thymus — Screening 163 aging-related molecules, the researchers noticed that mice lacking FOXO3, LMNA, or SIRT family genes both overproduce inflammatory cytokines and share one anatomical feature: a shrunken thymus.

That convergence led them to the thymic epithelial cells that secrete several hormones, among them thymosin α1, thymosin β4, thymopoietin, and thymulin. Thymulin stood out because prior work had shown it suppresses inflammatory cytokine production in human blood cells, and because its circulating activity declines with age to the point of being undetectable in older mice.

• Thymulin lowered cytokine output, but only in aged samples — Human blood cells treated with thymulin in the lab for 24 hours showed reduced cytokine expression in an age-dependent manner. Aged mice given daily injections for one week also showed a marked drop in the share of circulating cytokine-producing myeloid cells, while young mice showed no significant change.

In tumor-bearing aged mice, thymulin delayed tumor growth and improved survival across three separate breast cancer models, again with minimal effect in young animals. The researchers interpret this age dependence as thymulin restoring a signal that had gone missing rather than broadly revving up immunity.

• Thymulin acted on NF-κB, and the effects carried into T cells and drug response — NF-κB is a transcription factor that acts as an on-switch for inflammatory genes. It stays restrained until a signal frees it, at which point it travels to the DNA and turns those genes on. In immune cells from aged mice, thymulin interfered at both points: less NF-κB reached the DNA, and less of the release signal got through.

To confirm the effect ran through NF-κB rather than something else, the researchers used cells engineered to report NF-κB activity as a readable output. Thymulin dampened it. When they disabled the exact spot on the DNA where NF-κB attaches, thymulin stopped working altogether.

Inside the tumors of aged mice, thymulin increased T cell production of IFN-γ, a sign that those T cells were mounting an attack. In the same animals, tumors that had shown no response to anti-PD-L1 immunotherapy also became responsive once thymulin was given alongside it.

• Shrinkage begins young and reshapes the organ — Involution starts as early as 6 weeks of age in mice and within the first years of life in humans, reaching its peak at puberty, when sex hormone levels rise. The gland loses the clear boundary between its outer and inner zones, develops regions empty of epithelial cells, accumulates fibroblasts, and in humans fills with fat.

• Losing the gland surgically tracked with worse long-term outcomes — Adults who had their thymus removed (thymectomy) showed reduced T cell production and narrower T cell receptor diversity, and they carried higher risks of death and cancer than control patients and the general U.S. population.

Risk of cancer relapse was also elevated, while autoimmunity risk was transient and modest. Young adults who underwent thymectomy in early childhood carry a T cell profile resembling that of middle-aged and older individuals.

• Inflammation and thymic decline appear to reinforce each other — Inflammatory signals rise inside the aging thymus and can speed up its shrinkage. As the gland loses function, it may also release less thymulin, leaving inflammation less restrained.

Together, the findings suggest a self-reinforcing cycle in which inflammation accelerates thymus decline, and that decline allows inflammation to build further. However, no single experiment has followed the full sequence.

• Stress hormones can shrink the thymus quickly — Psychological stress, infection, fasting, and other stressors raise glucocorticoid hormones, which can cause developing T cells in the thymus to die. The gland may recover once stress hormone levels fall, but repeated or prolonged exposure could place added strain on thymic function.

• Low zinc is linked to reduced thymulin activity — Zinc levels tend to decline with age, and the review links this drop to lower thymulin activity and thymic involution. In aged mice, zinc supplementation restored the gland’s structure and its network of epithelial cells, although whether it can rejuvenate the thymus in generally healthy older adults remains uncertain.

• Vitamin D deficiency accelerated thymic aging in mice — Mice unable to produce the active form of vitamin D developed signs of premature thymic aging. Their thymic epithelial cells did not mature normally, and the gland became less effective at screening out potentially self-reactive T cells.

1. Lower your inflammatory burden — Your immune system functions better when it’s not stuck in low-grade defense mode. Start with the biggest inflammatory triggers. Cut seed oils such as soybean, canola, sunflower, safflower, corn and grapeseed, along with the restaurant meals and packaged foods that often contain them.

These oils deliver large amounts of linoleic acid (LA), a polyunsaturated fat that, in excess, gets incorporated into your cell membranes and mitochondria, where it may oxidize and contribute to chronic inflammation. Replace them with grass fed butter, ghee, or tallow. Reducing your exposure to plastics and heavily fragranced products also cuts down on xenoestrogens, hormone-disrupting chemicals that interfere with cellular signaling.

2. Eat for nutrients that support your thymus and immune function — Aside from zinc, vitamin A may help maintain thymus structure and immune coordination,⁸ and vitamin C may support the gland and T cell production.^9,10 Collagen-rich proteins also support tissue repair and immune recovery. You can obtain these nutrients from whole foods:

3. Use movement, heat, and light to support your body’s repair pathways — Your body relies on built-in signals that help maintain tissue health and cellular renewal. Several lifestyle strategies may help stimulate these processes without relying on hormone-based products:

4. Look into compounds that have been studied for thymic signaling — Certain natural substances have a long history of use for immune support. Astragalus, known as Huangqi in Traditional Chinese Medicine, is one example and has also been used to support endurance. Early research suggests that some of its compounds may help lower inflammatory stress, increase antioxidant activity, and improve immune signaling.¹¹

Researchers have also examined thymic peptides such as thymalin, thymosin β4, and thymosin α1 for roles in immune signaling, tissue repair, and antiviral activity, along with thymic protein A derived from calf thymus tissue.¹²

Most of these compounds are still considered experimental. Some require a prescription, and many are not FDA-approved for general use. They have been explored in regenerative and integrative medicine for chronic infections, immune dysfunction, and age-related immune decline. Consult a qualified health care provider if you’re considering any of these compounds.

5. Avoid the lifestyle factors that burden your immune system — Smoking appears especially harmful, as tobacco exposure continuously floods your body with oxidative stress and abnormal cell damage, so eliminating it removes one of the largest ongoing burdens.

Beyond that, prioritize deep, restorative sleep and maintain a consistent sleep-wake schedule. Get morning sunlight to help regulate immune signaling, circadian timing, and mitochondrial function, and avoid excessive alcohol, which disrupts gut integrity and immune regulation.

Keeping chronic stress in check matters too, since it keeps inflammatory hormones elevated. Daily movement that preserves muscle mass as you age supports your metabolic health alongside it.